TABLE 1.
Strain | Parent strain | Genotype | Reference or source |
---|---|---|---|
SC5314a | Clinical isolate | URA3/URA3 | 9a |
CAF2-1a | SC5314 | Δura3::imm434/URA3 | 8 |
CAI4a | CAF2-1 | Δura3::imm434/Δura3::imm434 | 8 |
CAI4-2312L | CAI4 | Δura3::imm434/Δura3::imm434 + URA3b | 3 |
CAI4-01 | CAI4 | ΔCamdr1::hisG-URA3-hisG/CaMDR1 | 3 |
CAI4-116 | CAI4-01 | ΔCamdr1::hisG-URA3-hisG/ΔCamdr1::hisG | 3 |
CJC01c | CAI4 | Δben38::hisG-URA3-hisG-URA3-hisG/BEN38 | Unpublished data |
CJC024c | CJC01 | Δben38::hisG-URA3-hisG/Δben38::hisG | Unpublished data |
CAI4-10 | CAI4 | Δrsr1::hisG-URA3-hisG/RSR1 | 29 |
CAI4-5 | CAI4-10 | Δrsr1::hisG-URA3-hisG/Δrsr1::hisG | 29 |
CWJ429 | CAI4 | ΔtopoI::hisG-URA3-hisG/TOPOI | 13 |
CWJ430 | CAI4 | ΔtopoI::hisG-URA3-hisG/TOPOI | 13 |
JKC19d | JKC17 | ΔcphI::hisG-URA3-hisG/ΔcphI::hisG | 18 |
CACB8B-5 | CACB8B-6 | Δchs3-3::hisG-URA3-hisG-URA3-hisG/Δchs3-2::hisG | 5 |
CACB8B-6 | CAI4 | Δchs3-3::hisG-URA3-hisG-URA3-hisG/CHS3 | 5 |
CACB10B-8 | CAI4 | Δchs3-1::hisG-URA3-hisG/CHS3 | 5 |
CACB10B-10 | CACB10B-8 | Δchs3-1::hisG-URA3-hisG/Δchs3-2::hisG | 5 |
CAG1e | CAI4 | Δint1::hisG-URA3-hisG/INT1 | 9 |
CAG3e | CAG1 | Δint1::hisG-URA3-hisG/Δint1::hisG | 9 |
CAG4e | CAG3 | Δint1::hisG/Δint1::hisG | 9 |
CAG5e | CAG4 | Δint1::hisG/Δint1::hisG + INT1-URA3f | 9 |
RSM3c | CAI4 | Δcdr1::hisG-URA3-hisG-URA3-hisG/CDR1 | Unpublished data |
RSM4c | CAI4 | Δcdr1::hisG-URA3-hisG/CDR1 | Unpublished data |
RSM7c | RSM3 | Δcdr1::hisG-URA3-hisG/Δcdr1::hisG | Unpublished data |
RSM11c | RSM4 | Δcdr1::hisG-URA3-hisG/Δcdr1::hisG | Unpublished data |
RSM17c | CAI4-116 | ΔCamdr1::hisG/ΔCamdr1::hisG/Δcdr1::hisG-URA3-hisG/Δcdr1::hisG | Unpublished data |
a Received from William A. Fonzi.
b + URA3 indicates that URA3 was reintegrated into the chromosome at the URA3 locus.
c Received from Millennium Pharmaceuticals, Inc., Cambridge, Mass.
d Received from Gerald R. Fink.
e Received from Judith Berman.
f +INTI-URA3 indicates that INT1-URA3 was reintegrated into the chromosome at the INT1 locus.